Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia

NCT00264108 · clinicaltrials.gov ↗

COMPLETED

Status

492

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Neoplasms

Interventions

DRUG: Darbepoetin alfa
DRUG: Epoetin alfa

Sponsor

Janssen-Cilag B.V.